Redefining the approach to rare diseases: the experience of "Casa dos Raros" in Brazil.

IF 1.5 Q4 GENETICS & HEREDITY
Roberto Giugliani, Bibiana Mello de Oliveira, Bruna Baierle Guaraná, Tássia Tonon, Franciele Barbosa Trapp, Fernando Machado da Costa, Larissa Pozzebon da Silva, Guilherme Baldo, Mariluce Riegel-Giugliani, Fabrizio Barbosa, Antoine Daher, Carolina Fischinger Moura de Souza
{"title":"Redefining the approach to rare diseases: the experience of \"Casa dos Raros\" in Brazil.","authors":"Roberto Giugliani, Bibiana Mello de Oliveira, Bruna Baierle Guaraná, Tássia Tonon, Franciele Barbosa Trapp, Fernando Machado da Costa, Larissa Pozzebon da Silva, Guilherme Baldo, Mariluce Riegel-Giugliani, Fabrizio Barbosa, Antoine Daher, Carolina Fischinger Moura de Souza","doi":"10.1007/s12687-025-00771-w","DOIUrl":null,"url":null,"abstract":"<p><p>Rare diseases include 6,000-8,000 different conditions, over 70% of them having a genetic cause. Most cases have early manifestations (in childhood and adolescence), and just a small fraction (around 5%) has specific therapies available. Nevertheless, appropriate management measures contribute to improve the quality of life of patients and families. They affect up to 3.5-5.9% of the world's population and are recently attracting attention from international agencies such as the United Nations and the World Health Organization. In Brazil, a condition is considered rare when there are no more than 65 people affected in each 100,000 inhabitants and it is estimated that around 12 million people in the country may present one of these conditions, which represents a significant burden to the family and to the health care system. Despite concrete advances observed in the last decades, there are still significant unmet needs for persons living with rare diseases in Brazil. With the main aim of shortening the journey of patients with rare diseases in Brazil, we envisioned a model that involves comprehensive clinical and laboratorial multiprofessional evaluations, with intensive use of telemedicine and genomics. The model includes a strong activity in education, training and research, and has several parallel initiatives (biobank, registry, undiagnosed disease program, information services, extramural diagnostic support), in addition to strategic partnerships, that make the overall project stronger. This report describes the system in place at the pilot unit of Casa dos Raros (that started activities in 2023, in Porto Alegre, Brazil) and the stimulating preliminary results, which indicate a significant reduction in the diagnostic journey. This model, that operates as a charity and does not charge any fees to patients and families, will be replicated in other regions of Brazil, with the opening of a second unit planned to occur in the near future in Sao Paulo.</p>","PeriodicalId":46965,"journal":{"name":"Journal of Community Genetics","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Community Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12687-025-00771-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Rare diseases include 6,000-8,000 different conditions, over 70% of them having a genetic cause. Most cases have early manifestations (in childhood and adolescence), and just a small fraction (around 5%) has specific therapies available. Nevertheless, appropriate management measures contribute to improve the quality of life of patients and families. They affect up to 3.5-5.9% of the world's population and are recently attracting attention from international agencies such as the United Nations and the World Health Organization. In Brazil, a condition is considered rare when there are no more than 65 people affected in each 100,000 inhabitants and it is estimated that around 12 million people in the country may present one of these conditions, which represents a significant burden to the family and to the health care system. Despite concrete advances observed in the last decades, there are still significant unmet needs for persons living with rare diseases in Brazil. With the main aim of shortening the journey of patients with rare diseases in Brazil, we envisioned a model that involves comprehensive clinical and laboratorial multiprofessional evaluations, with intensive use of telemedicine and genomics. The model includes a strong activity in education, training and research, and has several parallel initiatives (biobank, registry, undiagnosed disease program, information services, extramural diagnostic support), in addition to strategic partnerships, that make the overall project stronger. This report describes the system in place at the pilot unit of Casa dos Raros (that started activities in 2023, in Porto Alegre, Brazil) and the stimulating preliminary results, which indicate a significant reduction in the diagnostic journey. This model, that operates as a charity and does not charge any fees to patients and families, will be replicated in other regions of Brazil, with the opening of a second unit planned to occur in the near future in Sao Paulo.

重新定义治疗罕见病的方法:巴西“Casa dos Raros”的经验。
罕见病包括6000 - 8000种不同的病症,其中70%以上有遗传原因。大多数病例有早期表现(在儿童和青春期),只有一小部分(约5%)有特定的治疗方法。然而,适当的管理措施有助于改善患者和家属的生活质量。它们影响着世界人口的3.5-5.9%,最近引起了联合国和世界卫生组织等国际机构的注意。在巴西,当每10万居民中受影响的人数不超过65人时,就被认为是罕见的,据估计,该国约有1200万人可能患有这些疾病之一,这对家庭和卫生保健系统构成了重大负担。尽管在过去几十年中取得了具体进展,但巴西罕见病患者的需求仍未得到满足。为了缩短巴西罕见病患者的旅程,我们设想了一种模式,包括全面的临床和实验室多专业评估,并大量使用远程医疗和基因组学。该模式包括在教育、培训和研究方面开展强有力的活动,除了战略伙伴关系外,还有若干平行举措(生物库、登记、未确诊疾病方案、信息服务、校外诊断支持),使整个项目更加强大。本报告描述了Casa dos Raros试点单位(于2023年在巴西阿雷格里港开始活动)的系统以及令人鼓舞的初步结果,这些结果表明诊断旅程显着减少。这种模式作为慈善机构运作,不向患者和家属收取任何费用,将在巴西的其他地区复制,第二家医院计划不久的将来在圣保罗开业。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Community Genetics
Journal of Community Genetics GENETICS & HEREDITY-
CiteScore
3.30
自引率
5.30%
发文量
54
期刊介绍: The Journal of Community Genetics is an international forum for research in the ever-expanding field of community genetics, the art and science of applying medical genetics to human communities for the benefit of their individuals. Community genetics comprises all activities which identify persons at increased genetic risk and has an interest in assessing this risk, in order to enable those at risk to make informed decisions. Community genetics services thus encompass such activities as genetic screening, registration of genetic conditions in the population, routine preconceptional and prenatal genetic consultations, public education on genetic issues, and public debate on related ethical issues. The Journal of Community Genetics has a multidisciplinary scope. It covers medical genetics, epidemiology, genetics in primary care, public health aspects of genetics, and ethical, legal, social and economic issues. Its intention is to serve as a forum for community genetics worldwide, with a focus on low- and middle-income countries. The journal features original research papers, reviews, short communications, program reports, news, and correspondence. Program reports describe illustrative projects in the field of community genetics, e.g., design and progress of an educational program or the protocol and achievement of a gene bank. Case reports describing individual patients are not accepted.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信